StockData

NutriBand vs CollPlant Biotechnologies

NTRB and OPHI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NTRB and OPHI compare

CollPlant Biotechnologies grew revenue faster over the last twelve months (360% versus −37.3% for NutriBand).

NutriBand keeps more of each dollar of sales as profit, with a net margin of −430% compared with −485% at CollPlant Biotechnologies.

CollPlant Biotechnologies scores higher on the StockData Score (9 against 4 for NutriBand), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNTRBOPHI
Size and price
Market cap$68.0M–
Share price$5.59$3.60
Change, 1 year1.6%−81.8%
Change, 5 years−18.8%−98.0%
Beta (5Y)0.45−0.48
Employees50039
StockData Score
Total score49 (better)
Valuation score00
Growth score03 (better)
Performance score01 (better)
Health score45 (better)
Dividend score00
Valuation
P/S42.0×–
P/B12.8×–
Fair value$1.72–
Margin of safety−225%–
Growth
Revenue growth (TTM)−37.3%360% (better)
Revenue growth, 5Y average16.6% (better)−17.3%
Profitability
Gross margin33.1%64.8% (better)
Operating margin−436% (better)−484%
Net margin−430% (better)−485%
FCF margin–−398%
Return on equity−101% (better)−149%
Return on invested capital−320% (better)−1245%
Financial health
Debt / equity0.00 (better)0.00
Interest coverage−339.3×–
Current ratio4.21 (better)1.57
Altman Z-score28.53–
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions2.9%0.00%
Held by insiders24.5%–
Short interest, % of float1.5%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.